FDA Inspection 1034922 — Lin, James P MD Inc. d.b.a. Reproductive Fertility Center
The FDA completed an inspection of Lin, James P MD Inc. d.b.a. Reproductive Fertility Center on October 30, 2017 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 30, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Irvine, CA (United States)